11 Jun 2026
This report from NOCA, which is part of the National Cancer Audit Collaborating Centre (NATCAN), is an audit of the care received by women diagnosed with ovarian cancer between 1 January 2022 and 31 December 2023 in England, and between 1 January 2022 and 31 December 2024 in Wales.
Approximately four out of ten women diagnosed in England in 2023, and in Wales in 2024, had an emergency admission within 28 days prior to diagnosis
It found that approximately three out of four women in England, and seven out of ten women in Wales, with ovarian cancer were diagnosed with stage 2-4 disease. In terms of survival rates, 70% (England) and 73.8% (Wales) of women diagnosed in 2023 survived at least one year after the diagnosis. 58.4% (England) and 67.6% (Wales) of women diagnosed in 2022 survived at least two years after the diagnosis.
It also contains five key recommendations for improvement:
- Reduce the current rate of emergency admissions
- For women diagnosed with ovarian cancer within 28 days following an emergency admission, increase the proportion who receive treatment (surgery and/or chemotherapy)
- For women with stage 2 to 4 or unstaged ovarian cancer, increase the proportion of these women who receive treatment
- For women with epithelial ovarian cancer (stage 2 to 4, or unstaged), increase the proportion of these women who receive platinum-based chemotherapy
- Review opportunities to improve one- and two-year survival in women diagnosed with ovarian cancer.
Stay up-to-date: For notifications of future reports from HQIP, sign up to our mailing list.
